MktsMarkets

CVS Health Corporation
NYSE: CVSKey statistics
CVS News
Stories mentioning CVS from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 100,426,000 | 105,693,000 | 102,871,000 | 98,915,000 | 94,588,000 | 97,710,000 | 95,428,000 | 91,234,000 |
| Cost of Goods Sold | 55,444,000 | 59,060,000 | 57,045,000 | 54,005,000 | 51,057,000 | 55,268,000 | 52,948,000 | 49,998,000 |
| Gross Profit | 44,982,000 | 46,633,000 | 45,826,000 | 44,910,000 | 43,531,000 | 42,442,000 | 42,480,000 | 41,236,000 |
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 4,680,000 | 2,112,000 | (3,207,000) | 2,381,000 | 3,374,000 | 2,368,000 | 832,000 | 3,045,000 |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 32,000 | 29,000 | 26,000 | 29,000 | 28,000 | 25,000 | 25,000 | 24,000 |
| Pretax Income | 3,938,000 | 1,354,000 | (3,482,000) | 1,647,000 | 2,617,000 | 2,126,000 | 105,000 | 2,337,000 |
| Tax Provision | 981,000 | (1,569,000) | 508,000 | 634,000 | 835,000 | 503,000 | 34,000 | 569,000 |
| Net Income (Loss) | 2,943,000 | 2,943,000 | (3,975,000) | 1,021,000 | 1,779,000 | 1,644,000 | 87,000 | 1,770,000 |
| Earnings Per Share (Basic) | 2.31 | 2.32 | (3.13) | 0.81 | 1.41 | 1.31 | 0.07 | 1.41 |
| Earnings Per Share (Diluted) | 2.30 | 2.32 | (3.13) | 0.80 | 1.41 | 1.30 | 0.07 | 1.41 |
| Weighted Average Shares Outstanding (Basic) | 1,273,000 | 1,267,000 | 1,269,000 | 1,266,000 | 1,261,000 | 1,259,000 | 1,259,000 | 1,256,000 |
| Weighted Average Shares Outstanding (Diluted) | 1,279,000 | 1,271,000 | 1,269,000 | 1,270,000 | 1,264,000 | 1,262,000 | 1,259,000 | 1,259,000 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About CVS
CVS Health Corporation (NYSE: CVS) is a stock listed on the New York Stock Exchange under the ticker symbol CVS. It last traded at $89.79 (Nov 12, 2026, 4:00 PM ET), up 0.3% on the day. That gives CVS Health a market capitalisation of $114.5B and a price-to-earnings ratio of 10.4.
Over the past 52 weeks CVS has traded between $69.51 and $110.68.
Revenue for the quarter ended Mar 31, 2026 was $100.4B; net income $2.9B. Revenue was up 6.2% from $94.6B in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $100.4B | $2.9B | 2.9% |
| Dec 31, 2025 | $105.7B | $2.9B | 2.8% |
| Sep 30, 2025 | $102.9B | -$4.0B | -3.9% |
| Jun 30, 2025 | $98.9B | $1.0B | 1.0% |
From CVS Health’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…